Inventor · disambiguated record
Manoj Nerurkar
Also filed as: NERURKAR MANOJ
12 granted patents·14 pending applications·292 citations·filing 2003–2024
93Inventor score
Files withBRISTOL MYERS SQUIBB CO10OTSUKA PHARMA CO LTD10KOSTANSKI JANUSZ W2STEPS BIOSCIENCES INC2DALI MANISHA M1
Top patents by PatentIndex Score
26 records- 0197US7550445B2Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 23, 2009·51 cites·8 claims
- 0296US8030313B2Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2007·Granted Oct 4, 2011·37 cites·35 claims
- 0396US7807680B2Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2004·Granted Oct 5, 2010·63 cites·38 claims
- 0496US7115587B2Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 3, 2006·69 cites·24 claims
- 0591US9309316B2Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 12, 2016·14 cites·44 claims
- 0690US8722679B2Controlled release sterile injectable aripiprazole formulation and methodKOSTANSKI JANUSZ W·Filed 2007·Granted May 13, 2014·12 cites·36 claims
- 0790US8476239B2Stable protein formulationsDALI MANISHA M·Filed 2006·Granted Jul 2, 2013·40 cites·15 claims
- 0890US2024261280A1Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0980US9763935B2Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2014·Granted Sep 19, 2017·2 cites·7 claims
- 1080US8952013B2Controlled release sterile injectable aripiprazole formulation and methodKOSTANSKI JANUSZ W·Filed 2011·Granted Feb 10, 2015·3 cites·39 claims
- 1179US2021338663A1Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1277US2023277672A1METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONSBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1373US10265401B2Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 23, 2019·1 cites·16 claims
- 1472US2020061057A1Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 1570US2025099479A1Stable antiemetic emulsionsSTEPS BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1668US2009186903A1Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 1767US2018360965A1Stable subcutaneous protein formulations and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1866US2017348308A1Controlled release sterile injectable aripiprazole formulaton and methodOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 1966US2020230242A1METHODS OF USING CTLA4Ig SUBCUTANEOUS FORMULATIONSBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2065US8999952B2Aripiprazole complex formulation and methodOTSUKA PHARMA CO LTD·Filed 2013·Granted Apr 7, 2015·0 cites·6 claims
- 2165US2014018369A1Controlled release sterile injectable aripiprazole formulation and methodOTSUKA PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2264US12194047B2Stable antiemetic emulsionsSTEPS BIOSCIENCES INC·Filed 2021·Granted Jan 14, 2025·0 cites·16 claims
- 2362US2013045981A1Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 2459US2012053145A1Aripiprazole complex formulation and methodNERURKAR MANOJ·Filed 2011·Application pending·0 cites
- 2558US2011160224A1Aripiprazole complex formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 2657US2015328335A1Aripiprazole complex forumlation and methodOTSUKA PHARMA CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manoj Nerurkar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →